Supernus Pharmaceuticals, Inc. (SUPN)

CIK 1356576 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Supernus Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 202640001804567-26-000018
Nov 4, 202640001539215-26-000014
Nov 4, 202640001745316-26-000006
Nov 4, 202640001194020-26-000019
Nov 4, 202640002117599-26-000009
Nov 4, 202640001836067-26-000014
Nov 4, 202640001438462-26-000008
Nov 4, 202640001539937-26-000016
Nov 4, 202640001256088-26-000008
Nov 4, 202640001005544-26-000006
Nov 4, 202640001899935-26-000009
Nov 2, 2026S-8 POS0001104659-26-121038
Nov 2, 202640001539937-26-000014
Nov 2, 2026S-8 POS0001104659-26-121035
Nov 2, 2026S-8 POS0001104659-26-121032
Nov 2, 20268-K0001104659-26-121103
Nov 2, 202640002117599-26-000006
Nov 2, 2026S-8 POS0001104659-26-121040
Nov 2, 20268-K0001104659-26-121014
Nov 2, 202625-NSE0001354457-26-001045
Nov 2, 2026S-8 POS0001104659-26-121039
Nov 2, 202640001628280-26-068881
Nov 2, 202640001804567-26-000016
Nov 2, 202640001194020-26-000017
Nov 2, 202640001836067-26-000012